News

September 07, 2021 – Gothenburg, Sweden First data from the European Atherosclerosis Society (EAS) Familial Hypercholesterolaemia Studies Collaboration (FHSC) global registry of over 42,000 individuals from 56 countries, provides a unique snapshot into the worldwide burden and challenges of FH care. Detection needs to be earlier, with greater use of intensive lipid-lowering therapy, including combination … Read more

2019-04-26 Five years ago, the European Atherosclerosis Society (EAS) was a trailblazer in highlighting the underdiagnosis and undertreatment of familial hypercholesterolaemia (FH, inherited high cholesterol) in a Consensus Panel initiative.1 This was followed by subsequent statements, specifically focusing on homozygous FH,2 and importantly, FH in children and adolescents.3 Supported by other international evidence,4-7 the EAS recognised the worldwide lack … Read more